Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field.
Saved in:
| Title: | Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field. |
|---|---|
| Authors: | Lumley SF; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals, Oxford, UK., Mokaya J; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK., Maponga TG; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; National Health Laboratory Service, Tygerberg Business Unit, Cape Town, South Africa., Kramvis A; Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa., Dusheiko G; University of the Witwatersrand, Johannesburg, South Africa; Institute of Liver Studies, King's College Hospital, London, UK., Irving W; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK., Delphin M; The Francis Crick Institute, London, UK., Said Mohammed K; The Francis Crick Institute, London, UK., Downs LO; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals, Oxford, UK; Kenya Medical Research Institute Wellcome Trust, Kilifi, Kenya., Waddilove E; The Francis Crick Institute, London, UK., Anderson M; The Francis Crick Institute, London, UK; Africa Health Research Institute, Durban, South Africa; Botswana Harvard Health Partnership, Gaborone, Botswana., Iwuji C; Africa Health Research Institute, Durban, South Africa; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Msomi N; Discipline of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa., Ocama P; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Hamid S; Department of Medicine, Aga Khan University, Karachi, Pakistan., Adda D; World Hepatitis Alliance, Geneva, Switzerland; Center for Initiative and Development and Chagro-Care Trust, Jalingo, Nigeria., Halford R; World Hepatitis Alliance, Geneva, Switzerland., Kabagambe K; The National Organisation for People Living with Hepatitis B, Kampala, Uganda., Benschop KSM; National Institute for Public Health and the Environment, Bilthoven, Netherlands., Inzaule S; Amsterdam Institute for Global Health and Development and Department of Global Health, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Chan P; Department of Communicable Diseases, WHO South-East Asia Regional Office, New Delhi, India., Paul MAS; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland., Izumi K; Division of Programmes for Disease Control, WHO Western Pacific Regional Office, Manila, Philippines., Nisa T; Division of Programmes for Disease Control, WHO Western Pacific Regional Office, Manila, Philippines., De Dieu Iragena J; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland., Girón-Callejas A; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland., Kpossou AR; University of Abomey-Calavi, Abomey-Calavi, Benin., Jamiyu G; National AIDS, Viral Hepatitis and STIs Control Programme, Abuja, Nigeria., Emmanuel O; National AIDS, Viral Hepatitis and STIs Control Programme, Abuja, Nigeria., Balkissa M; Programme National de Lutte contre le Sida et les Hépatites (PNLSH), Ministère de la Santé Publique, de la Population et des Affaires Sociales, Niamey, Niger., Keita M; The Sectoral Unit for the Fight against HIV, Tuberculosis and Viral Hepatitis, Ministry of Health, Bamako, Mali., Prabdial-Sing N; National Institute for Communicable Diseases and National Health Laboratory Service and the Faculty of Health Sciences, Witwatersrand University, Johannesburg, South Africa; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa., Martinez A; Gorgas Memorial Institute for Health Studies, Panama City, Panama; Department of Microbiology and Immunology, University of Panama, Panama City, Panama., Magongo EN; Ministry of Health, STD/AIDS Control Program, Kampala, Uganda., Shao Y; National Centre for AIDS/STD Control and Prevention A, Chinese Center for Disease Control and Prevention, Changping Laboratory, Beijing, China., Sued O; HIV, STI, Viral Hepatitis and TB Unit, Department of Communicable Disease Prevention, Control, and Elimination, Pan American Health Organization, Washington, DC, USA., Sereno LS; HIV, STI, Viral Hepatitis and TB Unit, Department of Communicable Disease Prevention, Control, and Elimination, Pan American Health Organization, Washington, DC, USA., Shafer RW; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA., Lesi O; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland; University of Lagos, Lagos, Nigeria., Faini D; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland., Easterbrook P; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland., Duncombe C; International Association of Providers of AIDS Care, Washington DC, USA., Jordan MR; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA; Collaboratory for Emerging Infectious Diseases and Response, Tufts University, Medford, MA, USA., Matthews PC; Kenya Medical Research Institute Wellcome Trust, Kilifi, Kenya; Division of Infection and Immunity, University College London, London, UK; Department of Infectious Diseases, University College London Hospital, London, UK. Electronic address: philippa.matthews@crick.ac.uk. |
| Source: | The Lancet. Microbe [Lancet Microbe] 2025 Aug; Vol. 6 (8), pp. 101076. Date of Electronic Publication: 2025 Apr 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40220768 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lumley+SF%22">Lumley SF</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Mokaya+J%22">Mokaya J</searchLink>; Parasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Maponga+TG%22">Maponga TG</searchLink>; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; National Health Laboratory Service, Tygerberg Business Unit, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Kramvis+A%22">Kramvis A</searchLink>; Hepatitis Virus Diversity Research Unit, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Dusheiko+G%22">Dusheiko G</searchLink>; University of the Witwatersrand, Johannesburg, South Africa; Institute of Liver Studies, King's College Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Irving+W%22">Irving W</searchLink>; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Delphin+M%22">Delphin M</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Said+Mohammed+K%22">Said Mohammed K</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Downs+LO%22">Downs LO</searchLink>; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals, Oxford, UK; Kenya Medical Research Institute Wellcome Trust, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Waddilove+E%22">Waddilove E</searchLink>; The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Anderson+M%22">Anderson M</searchLink>; The Francis Crick Institute, London, UK; Africa Health Research Institute, Durban, South Africa; Botswana Harvard Health Partnership, Gaborone, Botswana.<br /><searchLink fieldCode="AU" term="%22Iwuji+C%22">Iwuji C</searchLink>; Africa Health Research Institute, Durban, South Africa; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Msomi+N%22">Msomi N</searchLink>; Discipline of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Ocama+P%22">Ocama P</searchLink>; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Hamid+S%22">Hamid S</searchLink>; Department of Medicine, Aga Khan University, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Adda+D%22">Adda D</searchLink>; World Hepatitis Alliance, Geneva, Switzerland; Center for Initiative and Development and Chagro-Care Trust, Jalingo, Nigeria.<br /><searchLink fieldCode="AU" term="%22Halford+R%22">Halford R</searchLink>; World Hepatitis Alliance, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kabagambe+K%22">Kabagambe K</searchLink>; The National Organisation for People Living with Hepatitis B, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Benschop+KSM%22">Benschop KSM</searchLink>; National Institute for Public Health and the Environment, Bilthoven, Netherlands.<br /><searchLink fieldCode="AU" term="%22Inzaule+S%22">Inzaule S</searchLink>; Amsterdam Institute for Global Health and Development and Department of Global Health, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Chan+P%22">Chan P</searchLink>; Department of Communicable Diseases, WHO South-East Asia Regional Office, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Paul+MAS%22">Paul MAS</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Izumi+K%22">Izumi K</searchLink>; Division of Programmes for Disease Control, WHO Western Pacific Regional Office, Manila, Philippines.<br /><searchLink fieldCode="AU" term="%22Nisa+T%22">Nisa T</searchLink>; Division of Programmes for Disease Control, WHO Western Pacific Regional Office, Manila, Philippines.<br /><searchLink fieldCode="AU" term="%22De+Dieu+Iragena+J%22">De Dieu Iragena J</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Girón-Callejas+A%22">Girón-Callejas A</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kpossou+AR%22">Kpossou AR</searchLink>; University of Abomey-Calavi, Abomey-Calavi, Benin.<br /><searchLink fieldCode="AU" term="%22Jamiyu+G%22">Jamiyu G</searchLink>; National AIDS, Viral Hepatitis and STIs Control Programme, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Emmanuel+O%22">Emmanuel O</searchLink>; National AIDS, Viral Hepatitis and STIs Control Programme, Abuja, Nigeria.<br /><searchLink fieldCode="AU" term="%22Balkissa+M%22">Balkissa M</searchLink>; Programme National de Lutte contre le Sida et les Hépatites (PNLSH), Ministère de la Santé Publique, de la Population et des Affaires Sociales, Niamey, Niger.<br /><searchLink fieldCode="AU" term="%22Keita+M%22">Keita M</searchLink>; The Sectoral Unit for the Fight against HIV, Tuberculosis and Viral Hepatitis, Ministry of Health, Bamako, Mali.<br /><searchLink fieldCode="AU" term="%22Prabdial-Sing+N%22">Prabdial-Sing N</searchLink>; National Institute for Communicable Diseases and National Health Laboratory Service and the Faculty of Health Sciences, Witwatersrand University, Johannesburg, South Africa; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Martinez+A%22">Martinez A</searchLink>; Gorgas Memorial Institute for Health Studies, Panama City, Panama; Department of Microbiology and Immunology, University of Panama, Panama City, Panama.<br /><searchLink fieldCode="AU" term="%22Magongo+EN%22">Magongo EN</searchLink>; Ministry of Health, STD/AIDS Control Program, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Shao+Y%22">Shao Y</searchLink>; National Centre for AIDS/STD Control and Prevention A, Chinese Center for Disease Control and Prevention, Changping Laboratory, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Sued+O%22">Sued O</searchLink>; HIV, STI, Viral Hepatitis and TB Unit, Department of Communicable Disease Prevention, Control, and Elimination, Pan American Health Organization, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Sereno+LS%22">Sereno LS</searchLink>; HIV, STI, Viral Hepatitis and TB Unit, Department of Communicable Disease Prevention, Control, and Elimination, Pan American Health Organization, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Shafer+RW%22">Shafer RW</searchLink>; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lesi+O%22">Lesi O</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland; University of Lagos, Lagos, Nigeria.<br /><searchLink fieldCode="AU" term="%22Faini+D%22">Faini D</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Easterbrook+P%22">Easterbrook P</searchLink>; Department of Global HIV, Hepatitis and Sexually Transmitted Infections, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Duncombe+C%22">Duncombe C</searchLink>; International Association of Providers of AIDS Care, Washington DC, USA.<br /><searchLink fieldCode="AU" term="%22Jordan+MR%22">Jordan MR</searchLink>; Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA; Collaboratory for Emerging Infectious Diseases and Response, Tufts University, Medford, MA, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+PC%22">Matthews PC</searchLink>; Kenya Medical Research Institute Wellcome Trust, Kilifi, Kenya; Division of Infection and Immunity, University College London, London, UK; Department of Infectious Diseases, University College London Hospital, London, UK. Electronic address: philippa.matthews@crick.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2025 Aug; Vol. 6 (8), pp. 101076. <i>Date of Electronic Publication: </i>2025 Apr 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40220768 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.lanmic.2025.101076 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101076 Titles: – TitleFull: Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lumley SF – PersonEntity: Name: NameFull: Mokaya J – PersonEntity: Name: NameFull: Maponga TG – PersonEntity: Name: NameFull: Kramvis A – PersonEntity: Name: NameFull: Dusheiko G – PersonEntity: Name: NameFull: Irving W – PersonEntity: Name: NameFull: Delphin M – PersonEntity: Name: NameFull: Said Mohammed K – PersonEntity: Name: NameFull: Downs LO – PersonEntity: Name: NameFull: Waddilove E – PersonEntity: Name: NameFull: Anderson M – PersonEntity: Name: NameFull: Iwuji C – PersonEntity: Name: NameFull: Msomi N – PersonEntity: Name: NameFull: Ocama P – PersonEntity: Name: NameFull: Hamid S – PersonEntity: Name: NameFull: Adda D – PersonEntity: Name: NameFull: Halford R – PersonEntity: Name: NameFull: Kabagambe K – PersonEntity: Name: NameFull: Benschop KSM – PersonEntity: Name: NameFull: Inzaule S – PersonEntity: Name: NameFull: Chan P – PersonEntity: Name: NameFull: Paul MAS – PersonEntity: Name: NameFull: Izumi K – PersonEntity: Name: NameFull: Nisa T – PersonEntity: Name: NameFull: De Dieu Iragena J – PersonEntity: Name: NameFull: Girón-Callejas A – PersonEntity: Name: NameFull: Kpossou AR – PersonEntity: Name: NameFull: Jamiyu G – PersonEntity: Name: NameFull: Emmanuel O – PersonEntity: Name: NameFull: Balkissa M – PersonEntity: Name: NameFull: Keita M – PersonEntity: Name: NameFull: Prabdial-Sing N – PersonEntity: Name: NameFull: Martinez A – PersonEntity: Name: NameFull: Magongo EN – PersonEntity: Name: NameFull: Shao Y – PersonEntity: Name: NameFull: Sued O – PersonEntity: Name: NameFull: Sereno LS – PersonEntity: Name: NameFull: Shafer RW – PersonEntity: Name: NameFull: Lesi O – PersonEntity: Name: NameFull: Faini D – PersonEntity: Name: NameFull: Easterbrook P – PersonEntity: Name: NameFull: Duncombe C – PersonEntity: Name: NameFull: Jordan MR – PersonEntity: Name: NameFull: Matthews PC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-5247 Numbering: – Type: volume Value: 6 – Type: issue Value: 8 Titles: – TitleFull: The Lancet. Microbe Type: main |
| ResultId | 1 |